US FDA Plans Education Efforts As Humira Biosimilars Launch

Adalimumab vial
Upcoming Humira biosimilar launches could help familiarize patients and providers with the products. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Biosimilars

More from Biosimilars & Generics